AsiaIPEX is a one-stop-shop for players in the IP industry, facilitating IP trade and connection to the IP world. Whether you are a patent owner interested in selling your IP, or a manufacturer looking to buy technologies to upgrade your operation, you will find the portal a useful resource.

"CT Mucus Score" - A New Scoring System that Quantifies Airway Mucus Impaction Using CT Scans

Technology Benefits
Asthma and COPD are common lung diseases that cause a large public health burden. One important pathologic mechanism is the accumulation of thick mucus (mucus plugs) in the airways, which restrict airflow. Detecting airway mucus plugs is difficult because they are not visible on chest X-rays and are rarely associated with any symptoms of cough or sputum production. For asthma, using blood inflammatory proteins as biomarkers of lung disease has also had limited success. To date, there is no method that specifically identifies the subgroup of patients with airway mucus impaction, leading to difficulties in directing mucoactive treatments and designing clinical trials to test therapies in this patient subgroup. However, this presented technology has addressed the issues previously described with a solution. Advantages: The first scoring system that uses CT lung imaging to generate a quantitative score for airway mucus impactionIdentifies specific patient subgroup with lung mucus plugs to direct mucoactive treatmentsResults can be used to directly impact clinical care of patients with asthma or COPD
Detailed Technology Description
UCSF researchers have developed a new method to measure the burden of intraluminal mucus using Multi-detector Computed Tomography (MDCT) by quantifying the number of bronchopulmonary segments that are completely occluded with mucus. This technology has been validated in patients with asthma using CT scans with normal dose radiation protocols.
Application No.
WO2017197360
Others

Stage of Development

Reduced to Practice


Looking for Partners

To develop & commercialize the technology as a stand-alone diagnostic or companion diagnostic to identify asthma or COPD patients with airway mucus plugs, and would therefore benefit from specific treatments, such as mucolytics, anti-inflammatory drugs, or protein therapeutics.


Data Availability

Under CDA / NDA


Related Materials



Tech ID/UC Case

29369/2016-100-0


Related Cases

2016-100-0

*Abstract

A novel method to measure airway mucus plugging using CT images from patients with asthma or chronic obstructive pulmonary disease (COPD) patients.

*IP Issue Date
Nov 16, 2017
*Principal Investigator

Name: David Gierada

Department:


Name: Scott Nagle

Department:


Name: John Newell

Department:


Name: Mark Schiebler

Department:


Name: Eleanor Dunican

Department:


Name: Brett Elicker

Department:


Name: John Fahy

Department:

Country/Region
USA

For more information, please click Here
Mobile Device